Action 301206 SHANDONG SANYUAN BIOTECHNOLOGY CO.,LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Shandong Sanyuan Biotechnology Co.,Ltd.

Actions

301206

CNE100005774

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 15/07/2024 		Varia. 5j. Varia. 1 janv.
24,45 CNY -1,96 % Graphique intraday de Shandong Sanyuan Biotechnology Co.,Ltd. +0,04 % -15,34 %
09/07 Sanyuan Biotechnology achève la construction d'une usine d'allulose MT
08/07 Shandong Sanyuan Biotechnology Co. Ltd. (SZSE:301206) annonce un rachat d'actions pour une valeur de 100 millions CNY. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Sanyuan Biotechnology Completes Construction of Allulose Plant
Shandong Sanyuan Biotechnology Co.,Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.
Shandong Sanyuan Biotechnology Co.,Ltd. authorizes a Buyback Plan.
Sanyuan Preparing to Appeal EU Plan to Impose Tariffs on China-Made Sweeteners
Shandong Sanyuan Biotechnology Co.,Ltd. Announces Final Cash Dividend on A Shares for 2023, Payable on 29 May 2024
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Certain A Shares of Shandong Sanyuan Biotechnology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 10-FEB-2024.
EU Opens Anti-Dumping Probe Into Sanyuan Biotechnology’s Erythritol Products
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Shandong Sanyuan Biotechnology Co.,Ltd.(XSEC:301206) added to S&P Global BMI Index
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Shandong Sanyuan Biotechnology Co.,Ltd. Implements Final Profit Distribution Plan (A Shares) for 2022, Payable on 21 June 2023
Shandong Sanyuan Biotechnology Co.,Ltd. Approves Cash Dividend for the Year 2022
Shandong Sanyuan Biotechnology Co.,Ltd. Proposal Final Cash Dividend for 2022
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Hapioneer announced that it has received $8.200000 million in funding from Shandong Sanyuan Biotechnology Co.,Ltd. and other investors.
Shandong Peixue Bioengineering Co., Ltd. announced that it expects to receive CNY 60 million in funding from Shandong Sanyuan Biotechnology Co.,Ltd.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 301206
  4. Actualités Shandong Sanyuan Biotechnology Co.,Ltd.
  5. Autres langues